The Veteran's service-connected hairy cell leukemia is in remission, and there is no evidence of active disease. The Board finds that a compensable rating is not warranted as the condition does not meet the criteria for anemia or aplastic anemia requiring continuous medication.
The deciding factor: The Veteran's hairy cell leukemia has been in clinical remission since approximately September 2000, and there is no evidence of active disease. The revised criteria do not apply as there is no diagnosis of anemia during the appeal period.
- Claimed conditions
- Hairy cell leukemia
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- July 16, 2020
- Citation
- 20047523
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 20047523.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's hairy cell leukemia residuals are rated at a 60 percent disability rating, effective from the date of the decision.
- Whole decision: Granted
The Board has granted a 10 percent rating for hairy cell leukemia residuals and a 20 percent rating for chronic fatigue, both of which are considered direct service connection cases.
- Whole decision: Remanded (sent back)
The Board has ordered the AOJ to confirm whether the Veteran was exposed to ionizing radiation from a helicopter floor system during active duty or ACDUTRA and to obtain a new medical opinion as to the etiology of his leukemia.
- Whole decision: Granted
The Veteran's hairy cell leukemia is granted as due to Agent Orange exposure.,Service connection for PTSD was remanded.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.